{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:33:06Z","timestamp":1777357986325,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Bladder cancer (BCa), particularly non-muscle invasive bladder cancer (NMIBC), remains a significant healthcare challenge due to high recurrence rates and limited non-surgical treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prostate stem cell antigen (PSCA)-transduced HEK-BlueTMhTLR9 and PSCA-positive SW780 bladder cancer cells were stimulated with PSCA-targeting NANO:BICs, which were assembled from a scFv(AM1)-KiBAP, NeutrAvidin, and the Toll-like Receptor 9 (TLR9) agonist ODN2006. Functional analyses included a secreted embryonic alkaline phosphatase (SEAP) reporter assay to measure TLR9 activation, a Cytometric Bead Array for cytokine quantification, and confocal microscopy to assess cellular uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PSCA-targeting NANO:BICs demonstrated significantly enhanced uptake into PSCA-positive cancer cells compared to non-targeting controls, with the PSCA receptor increasing uptake by a factor of 3.63. This targeted delivery led to potent activation of the TLR9 signaling pathway, evidenced by a robust reporter gene response and secretion of key antiviral cytokines, including type I and III interferons and the chemokine IP-10.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings highlight the potential of this approach not only for reinvigorating anti-tumor immune responses in BCa but also for broader applications in other PSCA-expressing malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1739618","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:35:13Z","timestamp":1777354513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Max","family":"Iltzsche","sequence":"first","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Wetterling","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Section Experimental Neurosurgery and Tumor Immunology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lissy","family":"Jilek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Section Experimental Neurosurgery and Tumor Immunology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nahhas","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"Hesse","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Tietze","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Section Experimental Neurosurgery and Tumor Immunology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Temme","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Section Experimental Neurosurgery and Tumor Immunology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]},{"name":"German Cancer Consortium (DKTK), Partner Site Dresden","place":["Dresden, Germany"]},{"name":"National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR)","place":["Heidelberg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Fuessel","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]},{"name":"German Cancer Consortium (DKTK), Partner Site Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kind","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden","place":["Dresden, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31020079","article-title":"BCG and alternative therapies to BCG therapy for non-muscle-invasive bladder cancer","volume":"31","author":"Lidagoster","year":"2024","journal-title":"Curr Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12818","article-title":"Toll-like receptors: The role in bladder cancer development, progression and immunotherapy","volume":"90","author":"Ohadian Moghadam","year":"2019","journal-title":"Scandinavian J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12075","article-title":"B acillus C almette\u2013 G uerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2016-2348","article-title":"Abstract 2348: Nanovaccine : A novel immunotherapeutic strategy to treat bladder cancer","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res"},{"key":"B7","article-title":"Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer","volume":"60","author":"Dannull","year":"2000","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06153.x","article-title":"Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder","volume":"97","author":"Elsamman","year":"2006","journal-title":"BJU Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20608","article-title":"Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells","volume":"67","author":"Morgenroth","year":"2007","journal-title":"Prostate"},{"key":"B10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1038\/s41598-019-40032-8","article-title":"Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis","volume":"9","author":"Schau","year":"2019","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.4c00001","article-title":"Label-free interference imaging of intracellular trafficking","volume":"57","author":"Park","year":"2024","journal-title":"Accounts Chem Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092023","article-title":"Intracellular trafficking of HBV particles","volume":"9","author":"Jiang","year":"2020","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2006.443","article-title":"Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery","volume":"6","author":"Chavanpatil","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"key":"B15","first-page":"5","article-title":"Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors","volume":"49","author":"Fogh","year":"1978","journal-title":"Natl Cancer Institute Monograph"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400330","article-title":"DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy","volume":"194","author":"T\u00f6pfer","year":"2015","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.11.8873-8883.1998","article-title":"High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells","volume":"72","author":"Mochizuki","year":"1998","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/viro.2001.0903","article-title":"Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells","volume":"284","author":"Kalajzic","year":"2001","journal-title":"Virology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0407","article-title":"Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy","volume":"12","author":"Blehm","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191315","article-title":"Biotin-tagged proteins: Reagents for efficient ELISA-based serodiagnosis and phage display-based affinity selection","volume":"13","author":"Verma","year":"2018","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0031-3203(94)e0043-k","article-title":"Image thresholding by minimizing the measures\u00a0of\u00a0fuzziness","volume":"28","author":"Huang","year":"1997","journal-title":"Pattern Recognition"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081925","article-title":"Targeted transposition of minicircle DNA using single-chain antibody conjugated cyclodextrin-modified poly (Propylene imine) nanocarriers","volume":"14","author":"Jugel","year":"2022","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140391","article-title":"Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators","volume":"212","author":"Flierl","year":"2015","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/bc1002423","article-title":"Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles","volume":"21","author":"Patel","year":"2010","journal-title":"Bioconjugate Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1039\/D0SC01255F","article-title":"Investigation of cellular uptake mechanism of functionalised gold nanoparticles into breast cancer using SERS","volume":"11","author":"Kapara","year":"2020","journal-title":"Chem Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1739618\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:35:14Z","timestamp":1777354514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1739618\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1739618"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1739618","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1739618"}}